...
nnvc-img

NanoViricides Inc, Common Stock

NNVC

ASQ

$1.519

+$0.03

(2.01%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$18.83M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
717.89K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.97
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1 L
$3.59 H
$1.519

About NanoViricides Inc, Common Stock

NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company's product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical trial for the evaluation of safety and tolerability; NV-387 as an active ingredient of drug product formulations for the treatment of COVID infections comprising NV-CoV-2 Oral Syrup and NV-CoV-2 Oral Gummies, a semi-solid fixed-dose form, which are in phase 1a/1b human clinical trials for enabling body-weight-based dose titration as is required for pediatric treatments. It also offers NV-387 Solution for injection, infusion, and inhalation to treat severe cases that are not hospitalized and carried out by an injection; and injectable solution that delivered directly into the lungs as a fog created using portable battery operated nebulizer devices, which enables action at infection by a respiratory virus, such as coronaviruses, RSV, influenzas, human meta-pneumovirus, certain adenoviruses, and other infections, that can lead to severe pneumonia. In addition, the company develops NV-HHV-1, a skin cream for the treatment of Shingles rash, which has completed non-clinical pharmacology studies; oral drug with NV-HHV-1 as the active ingredient for the treatment of HSV-1 cold sores and HSV-2 genital ulcers; and other drug candidates in HIVCide program for the treatment of Dengue and Ebola virus, as well as provides Nanoviricide platform technology to treat various types of viruses. NanoViricides, Inc. was incorporated in 2005 and is headquartered in Shelton, Connecticut. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameNNVCSectorS&P500
1-Week Return3.38%-0.94%-2.6%
1-Month Return12.5%-5.08%-1.08%
3-Month Return-0.65%-10.62%3.45%
6-Month Return-20.31%-6.18%8.57%
1-Year Return47.07%1.98%24.3%
3-Year Return-61.17%-0.93%25.58%
5-Year Return-42.05%33.84%84.07%
10-Year Return-97.29%102.52%185.12%

Financials

Jun '20Jun '21Jun '22Jun '23Jun '245YR TREND
Total Revenue-----[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Cost of Revenue699.72K704.54K723.33K747.53K759.01K[{"date":"2020-06-30","value":92.19,"profit":true},{"date":"2021-06-30","value":92.82,"profit":true},{"date":"2022-06-30","value":95.3,"profit":true},{"date":"2023-06-30","value":98.49,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Gross Profit(699.72K)(704.54K)(723.33K)(747.53K)(759.01K)[{"date":"2020-06-30","value":-69972400,"profit":false},{"date":"2021-06-30","value":-70453800,"profit":false},{"date":"2022-06-30","value":-72332500,"profit":false},{"date":"2023-06-30","value":-74752900,"profit":false},{"date":"2024-06-30","value":-75901400,"profit":false}]
Gross Margin-----[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Operating Expenses8.00M8.74M8.11M8.94M8.52M[{"date":"2020-06-30","value":89.41,"profit":true},{"date":"2021-06-30","value":97.77,"profit":true},{"date":"2022-06-30","value":90.72,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":95.22,"profit":true}]
Operating Income(8.00M)(8.74M)(8.11M)(8.94M)(8.52M)[{"date":"2020-06-30","value":-799645900,"profit":false},{"date":"2021-06-30","value":-874410600,"profit":false},{"date":"2022-06-30","value":-811359900,"profit":false},{"date":"2023-06-30","value":-894346800,"profit":false},{"date":"2024-06-30","value":-851611100,"profit":false}]
Total Non-Operating Income/Expense(5.53M)(154.14K)13.47K709.79K443.93K[{"date":"2020-06-30","value":-778.63,"profit":false},{"date":"2021-06-30","value":-21.72,"profit":false},{"date":"2022-06-30","value":1.9,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":62.54,"profit":true}]
Pre-Tax Income(13.45M)(8.82M)(8.11M)(8.59M)(8.29M)[{"date":"2020-06-30","value":-1344653800,"profit":false},{"date":"2021-06-30","value":-882218900,"profit":false},{"date":"2022-06-30","value":-810686300,"profit":false},{"date":"2023-06-30","value":-858857300,"profit":false},{"date":"2024-06-30","value":-829414600,"profit":false}]
Income Taxes(49.00K)85.41K(6.74K)355.83K-[{"date":"2020-06-30","value":-13.77,"profit":false},{"date":"2021-06-30","value":24,"profit":true},{"date":"2022-06-30","value":-1.89,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Income After Taxes(13.40M)(8.91M)(8.10M)(8.94M)-[{"date":"2020-06-30","value":-1339753900,"profit":false},{"date":"2021-06-30","value":-890759400,"profit":false},{"date":"2022-06-30","value":-810012700,"profit":false},{"date":"2023-06-30","value":-894440600,"profit":false},{"date":"2024-06-30","value":"-","profit":true}]
Income From Continuous Operations(13.45M)(8.82M)(8.11M)(8.59M)(8.29M)[{"date":"2020-06-30","value":-1344653800,"profit":false},{"date":"2021-06-30","value":-882218900,"profit":false},{"date":"2022-06-30","value":-810686300,"profit":false},{"date":"2023-06-30","value":-858857300,"profit":false},{"date":"2024-06-30","value":-829414600,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Net Income(13.40M)(8.91M)(8.10M)(8.59M)(8.29M)[{"date":"2020-06-30","value":-1339753900,"profit":false},{"date":"2021-06-30","value":-890759400,"profit":false},{"date":"2022-06-30","value":-810012700,"profit":false},{"date":"2023-06-30","value":-858857300,"profit":false},{"date":"2024-06-30","value":-829414600,"profit":false}]
EPS (Diluted)(2.38)(0.81)(0.71)(0.74)(0.68)[{"date":"2020-06-30","value":-238,"profit":false},{"date":"2021-06-30","value":-81,"profit":false},{"date":"2022-06-30","value":-71,"profit":false},{"date":"2023-06-30","value":-74.15,"profit":false},{"date":"2024-06-30","value":-68,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NNVC
Cash Ratio 2.37
Current Ratio 2.48

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NNVC
ROA (LTM) -35.81%
ROE (LTM) -63.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NNVC
Debt Ratio Lower is generally better. Negative is bad. 0.14
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.86

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NNVC
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 2.11
Price/FCF NM
EV/R 0.00
EV/Ebitda NM
PEG NM

FAQs

What is NanoViricides Inc share price today?

NanoViricides Inc (NNVC) share price today is $1.519

Can Indians buy NanoViricides Inc shares?

Yes, Indians can buy shares of NanoViricides Inc (NNVC) on Vested. To buy NanoViricides Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NNVC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of NanoViricides Inc be purchased?

Yes, you can purchase fractional shares of NanoViricides Inc (NNVC) via the Vested app. You can start investing in NanoViricides Inc (NNVC) with a minimum investment of $1.

How to invest in NanoViricides Inc shares from India?

You can invest in shares of NanoViricides Inc (NNVC) via Vested in three simple steps:

  • Click on Sign Up or Invest in NNVC stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in NanoViricides Inc shares
What is NanoViricides Inc 52-week high and low stock price?

The 52-week high price of NanoViricides Inc (NNVC) is $3.59. The 52-week low price of NanoViricides Inc (NNVC) is $1.

What is NanoViricides Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of NanoViricides Inc (NNVC) is

What is NanoViricides Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of NanoViricides Inc (NNVC) is 2.11

What is NanoViricides Inc dividend yield?

The dividend yield of NanoViricides Inc (NNVC) is 0.00%

What is the Market Cap of NanoViricides Inc?

The market capitalization of NanoViricides Inc (NNVC) is $18.83M

What is NanoViricides Inc’s stock symbol?

The stock symbol (or ticker) of NanoViricides Inc is NNVC

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top